Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study — Stella

Home/Kidney Transplant; Complications/The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study

View on ClinicalTrials.gov

Recruiting

Back to Kidney Transplant; Complications trials

The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

UNC Eastowne Kidney Transplant Clinic, Chapel Hill, North Carolina

Key details

Phase

Safety & dosing

Sponsor

University of North Carolina, Chapel Hill

Collaborators

Bayer, Weill Medical College of Cornell University

Enrollment target

~100 participants

Started

April 2024

Primary completion

March 2027

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.